A vaccine to prevent breast cancer: the first clinical study is underway

IT’S ONE of the challenges of cancer immunotherapy: making vaccines that, just like the flu (and coronavirus) vaccine, train our immune systems to recognize and eliminate cancer cells should cancer develop. In a word, to prevent cancer. It has been trying for many years and now the first clinical study on a possible vaccine for triple negative breast cancer is about to start: the most difficult to treat among breast cancers and, consequently, considered the most aggressive.